These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30953619)

  • 1. Search for biomarkers of Alzheimer's disease: Recent insights, current challenges and future prospects.
    Hrubešová K; Fousková M; Habartová L; Fišar Z; Jirák R; Raboch J; Setnička V
    Clin Biochem; 2019 Oct; 72():39-51. PubMed ID: 30953619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New biomarkers for Alzheimer's disease in cerebrospinal fluid and blood].
    Vogelgsang J; Wiltfang J
    Nervenarzt; 2019 Sep; 90(9):907-913. PubMed ID: 31407045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saliva, an easily accessible fluid as diagnostic tool and potent stem cell source for Alzheimer's Disease: Present and future applications.
    Reale M; Gonzales-Portillo I; Borlongan CV
    Brain Res; 2020 Jan; 1727():146535. PubMed ID: 31669827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary beta amyloid protein levels are detectable and differentiate patients with Alzheimer's disease dementia from normal controls: preliminary findings.
    Sabbagh MN; Shi J; Lee M; Arnold L; Al-Hasan Y; Heim J; McGeer P
    BMC Neurol; 2018 Sep; 18(1):155. PubMed ID: 30257642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of biomarkers in clinical trials for Alzheimer disease.
    Thal LJ; Kantarci K; Reiman EM; Klunk WE; Weiner MW; Zetterberg H; Galasko D; Praticò D; Griffin S; Schenk D; Siemers E
    Alzheimer Dis Assoc Disord; 2006; 20(1):6-15. PubMed ID: 16493230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers for Alzheimer's disease: current status and prospects for the future.
    Blennow K; Zetterberg H
    J Intern Med; 2018 Dec; 284(6):643-663. PubMed ID: 30051512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory biomarkers in Alzheimer's disease.
    Steinerman JR; Honig LS
    Curr Neurol Neurosci Rep; 2007 Sep; 7(5):381-7. PubMed ID: 17764627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical challenges related to the use of biomarker ratios for the biological diagnosis of Alzheimer's disease.
    Lehmann S; Delaby C; Paquet C; Gabelle A
    Clin Chem Lab Med; 2015 Jul; 53(8):e175-7. PubMed ID: 25870963
    [No Abstract]   [Full Text] [Related]  

  • 9. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplex immunoassay measurement of amyloid-β
    Vogelgsang J; Shahpasand-Kroner H; Vogelgsang R; Streit F; Vukovich R; Wiltfang J
    Exp Brain Res; 2018 May; 236(5):1241-1250. PubMed ID: 29480353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High performance plasma amyloid-β biomarkers for Alzheimer's disease.
    Nakamura A; Kaneko N; Villemagne VL; Kato T; Doecke J; Doré V; Fowler C; Li QX; Martins R; Rowe C; Tomita T; Matsuzaki K; Ishii K; Ishii K; Arahata Y; Iwamoto S; Ito K; Tanaka K; Masters CL; Yanagisawa K
    Nature; 2018 Feb; 554(7691):249-254. PubMed ID: 29420472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease.
    Prvulovic D; Hampel H
    Clin Chem Lab Med; 2011 Mar; 49(3):367-74. PubMed ID: 21342022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
    Fortea J; Carmona-Iragui M; Benejam B; Fernández S; Videla L; Barroeta I; Alcolea D; Pegueroles J; Muñoz L; Belbin O; de Leon MJ; Maceski AM; Hirtz C; Clarimón J; Videla S; Delaby C; Lehmann S; Blesa R; Lleó A
    Lancet Neurol; 2018 Oct; 17(10):860-869. PubMed ID: 30172624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease.
    Scheltens P; Blennow K; Breteler MM; de Strooper B; Frisoni GB; Salloway S; Van der Flier WM
    Lancet; 2016 Jul; 388(10043):505-17. PubMed ID: 26921134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panel.
    Somers C; Goossens J; Engelborghs S; Bjerke M
    Biomark Med; 2017 Feb; 11(2):169-178. PubMed ID: 28111962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological markers in Alzheimer's disease.
    Grundke-Iqbal I; Rolkova G; Konstekova E; Iqbal K
    Bratisl Lek Listy; 2006; 107(9-10):359-65. PubMed ID: 17262988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cerebrospinal fluid biomarkers of Alzheimer's disease in current clinical practice].
    Magnin E; Popp J
    Rev Med Suisse; 2016 Apr; 12(515):791-4. PubMed ID: 27276722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative.
    Molinuevo JL; Blennow K; Dubois B; Engelborghs S; Lewczuk P; Perret-Liaudet A; Teunissen CE; Parnetti L
    Alzheimers Dement; 2014 Nov; 10(6):808-17. PubMed ID: 25150736
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.